Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Orain

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Biomolecular Screening|February 4, 2014
Fluorescence Lifetime-Based Competitive Binding Assays for Measuring the Binding Potency of Protease Inhibitors In VitroAndreas Boettcher, Nathalie Gradoux, Edwige Lorthiois, et al.
Psychopharmacology|July 18, 2009
Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effectMarkus Fendt, Hugo Bürki, Stefan Imobersteg, et al.
Plos One|November 21, 2017
Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivoUlf Guendisch, Jessica Weiss, Florence Ecoeur, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2011
Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activityManuel Koller, Kurt Lingenhoehl, Markus Schmutz, et al.
Journal of Medicinal Chemistry|April 27, 2017
Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and AngiogenesisJuraj Velcicky, Wolfgang Miltz, Berndt Oberhauser, et al.
Chemmedchem|December 1, 2016
Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse AgonistsSamuel Hintermann, Christine Guntermann, Henri Mattes, et al.
Chemmedchem|November 19, 2016
Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor AntagonistDavid Orain, Engin Tasdelen, Samuel Haessig, et al.
Chemmedchem|September 4, 2010
Design and synthesis of selective and potent orally active S1P5 agonistsHenri Mattes, Kumlesh Kumar Dev, Rochdi Bouhelal, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonistsDavid Orain, Silvio Ofner, Manuel Koller, et al.
Journal of Medicinal Chemistry|July 11, 2018
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation ModelDavid A Carcache, Anna Vulpetti, Joerg Kallen, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Biomolecular Screening|February 4, 2014
Fluorescence Lifetime-Based Competitive Binding Assays for Measuring the Binding Potency of Protease Inhibitors In VitroAndreas Boettcher, Nathalie Gradoux, Edwige Lorthiois, et al.
Psychopharmacology|July 18, 2009
Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effectMarkus Fendt, Hugo Bürki, Stefan Imobersteg, et al.
Plos One|November 21, 2017
Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivoUlf Guendisch, Jessica Weiss, Florence Ecoeur, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2011
Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activityManuel Koller, Kurt Lingenhoehl, Markus Schmutz, et al.
Journal of Medicinal Chemistry|April 27, 2017
Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and AngiogenesisJuraj Velcicky, Wolfgang Miltz, Berndt Oberhauser, et al.
Chemmedchem|December 1, 2016
Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse AgonistsSamuel Hintermann, Christine Guntermann, Henri Mattes, et al.
Chemmedchem|November 19, 2016
Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor AntagonistDavid Orain, Engin Tasdelen, Samuel Haessig, et al.
Chemmedchem|September 4, 2010
Design and synthesis of selective and potent orally active S1P5 agonistsHenri Mattes, Kumlesh Kumar Dev, Rochdi Bouhelal, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonistsDavid Orain, Silvio Ofner, Manuel Koller, et al.
Journal of Medicinal Chemistry|July 11, 2018
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation ModelDavid A Carcache, Anna Vulpetti, Joerg Kallen, et al.
Pageof 3